lectin conjugated antibody Search Results


95
Vector Laboratories fluorescein labeled lycopersicon esculentum (tomato) lectin (lel, tl)
Fluorescein Labeled Lycopersicon Esculentum (Tomato) Lectin (Lel, Tl), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein labeled lycopersicon esculentum (tomato) lectin (lel, tl)/product/Vector Laboratories
Average 95 stars, based on 1 article reviews
fluorescein labeled lycopersicon esculentum (tomato) lectin (lel, tl) - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

94
Proteintech galectin171 3 polyclonal antibody
Galectin171 3 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/galectin171 3 polyclonal antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
galectin171 3 polyclonal antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Proteintech asgr1 antibody
( A ) Whole-body IVIS imaging of mice injected with nonlabeled LNP-siRNA (control group) or LNPs loaded Cy5-labeled siRNA. ( B ) Representative IVIS image illustrating the distribution of LNPs across various organs. ( C ) Flow cytometry analysis showing cellular uptake of Cy5-siRNA in hepatocytes. <t>ASGR1</t> was used as a hepatocyte specific marker. ( D ) Distribution of Cy5-labeled siRNA among different liver cell populations in healthy mice and MASH mice fed an MCD diet for 8 weeks. Data were presented as the percentage of Cy5-positive cells within each cell type based on FACS analysis. EC, endothelial cells; HSCs, hepatic stellate cells; DCs, dendritic cells. ( E to G ) Time-course analysis of hepatic Sptlc2 mRNA levels and SPTLC2 protein levels following a single intravenous dose of LNP-siRNA (0.3 mg/kg) in MASH mice fed an MCD diet for 4 weeks. Glyceraldehyde-3-phosphate dehydrogenase was used as a loading control for Western blot analysis, and protein expression levels were normalized to that on day 2 postdosing of LNP-Scrambled siRNA (control). ( H ) Time-course analysis of hepatic Sptlc2 mRNA levels in healthy mice following siRNA treatment at 0.3 mg/kg per dose, administered either once or twice weekly. The once-weekly group received doses on days 0 and 7, while the twice-weekly group received doses on days 0, 3, 7, and 10. N = 3 mice per group. * P < 0.05, ** P < 0.01, and *** P < 0.001; one-way ANOVA.
Asgr1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/asgr1 antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
asgr1 antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Proteintech lgals3
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Lgals3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lgals3/product/Proteintech
Average 93 stars, based on 1 article reviews
lgals3 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Seikagaku corporation fluorescein isothiocyanate (fitc) conjugated lectins
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Fluorescein Isothiocyanate (Fitc) Conjugated Lectins, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein isothiocyanate (fitc) conjugated lectins/product/Seikagaku corporation
Average 90 stars, based on 1 article reviews
fluorescein isothiocyanate (fitc) conjugated lectins - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Technical Manufacturing Company hrp-conjugated lectins or antibodies
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Hrp Conjugated Lectins Or Antibodies, supplied by Technical Manufacturing Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrp-conjugated lectins or antibodies/product/Technical Manufacturing Company
Average 90 stars, based on 1 article reviews
hrp-conjugated lectins or antibodies - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Becton Dickinson fitc-conjugated goat anti-mouse antibody lectin
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Fitc Conjugated Goat Anti Mouse Antibody Lectin, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc-conjugated goat anti-mouse antibody lectin/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
fitc-conjugated goat anti-mouse antibody lectin - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
EY Laboratories fitc-conjugated anti-dolichos biflorus lectin (dba) antibody
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Fitc Conjugated Anti Dolichos Biflorus Lectin (Dba) Antibody, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc-conjugated anti-dolichos biflorus lectin (dba) antibody/product/EY Laboratories
Average 90 stars, based on 1 article reviews
fitc-conjugated anti-dolichos biflorus lectin (dba) antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
EY Laboratories fluorescein-conjugated lectin helix pornotia
( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, <t>LGALS3,</t> and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .
Fluorescein Conjugated Lectin Helix Pornotia, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein-conjugated lectin helix pornotia/product/EY Laboratories
Average 90 stars, based on 1 article reviews
fluorescein-conjugated lectin helix pornotia - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
EY Laboratories plant lectins conjugated rhodamine
<t> Lectins </t> detected in the neurons by co-localization .
Plant Lectins Conjugated Rhodamine, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plant lectins conjugated rhodamine/product/EY Laboratories
Average 90 stars, based on 1 article reviews
plant lectins conjugated rhodamine - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
US Biological Life Sciences hrp-conjugated galanthus nivalis lectin (gna
Protein and <t>lectin</t> staining of released E. coli surface proteins. NT: Non-treated, AH: Acid-hydrolyzed, LF: AIEC LF82. MG: E. coli MG1655. (A) Coomassie blue stain, (B) Anti-type I fimbriae-FITC staining, (C) ConA-HRP staining.
Hrp Conjugated Galanthus Nivalis Lectin (Gna, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hrp-conjugated galanthus nivalis lectin (gna/product/US Biological Life Sciences
Average 90 stars, based on 1 article reviews
hrp-conjugated galanthus nivalis lectin (gna - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Maravai LifeSciences fluorescein isothiocyanate (fitc)-conjugated lotus tetragonolobus lectin (ltl) antibody
Protein and <t>lectin</t> staining of released E. coli surface proteins. NT: Non-treated, AH: Acid-hydrolyzed, LF: AIEC LF82. MG: E. coli MG1655. (A) Coomassie blue stain, (B) Anti-type I fimbriae-FITC staining, (C) ConA-HRP staining.
Fluorescein Isothiocyanate (Fitc) Conjugated Lotus Tetragonolobus Lectin (Ltl) Antibody, supplied by Maravai LifeSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein isothiocyanate (fitc)-conjugated lotus tetragonolobus lectin (ltl) antibody/product/Maravai LifeSciences
Average 90 stars, based on 1 article reviews
fluorescein isothiocyanate (fitc)-conjugated lotus tetragonolobus lectin (ltl) antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Whole-body IVIS imaging of mice injected with nonlabeled LNP-siRNA (control group) or LNPs loaded Cy5-labeled siRNA. ( B ) Representative IVIS image illustrating the distribution of LNPs across various organs. ( C ) Flow cytometry analysis showing cellular uptake of Cy5-siRNA in hepatocytes. ASGR1 was used as a hepatocyte specific marker. ( D ) Distribution of Cy5-labeled siRNA among different liver cell populations in healthy mice and MASH mice fed an MCD diet for 8 weeks. Data were presented as the percentage of Cy5-positive cells within each cell type based on FACS analysis. EC, endothelial cells; HSCs, hepatic stellate cells; DCs, dendritic cells. ( E to G ) Time-course analysis of hepatic Sptlc2 mRNA levels and SPTLC2 protein levels following a single intravenous dose of LNP-siRNA (0.3 mg/kg) in MASH mice fed an MCD diet for 4 weeks. Glyceraldehyde-3-phosphate dehydrogenase was used as a loading control for Western blot analysis, and protein expression levels were normalized to that on day 2 postdosing of LNP-Scrambled siRNA (control). ( H ) Time-course analysis of hepatic Sptlc2 mRNA levels in healthy mice following siRNA treatment at 0.3 mg/kg per dose, administered either once or twice weekly. The once-weekly group received doses on days 0 and 7, while the twice-weekly group received doses on days 0, 3, 7, and 10. N = 3 mice per group. * P < 0.05, ** P < 0.01, and *** P < 0.001; one-way ANOVA.

Journal: Science Advances

Article Title: Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH

doi: 10.1126/sciadv.adx2681

Figure Lengend Snippet: ( A ) Whole-body IVIS imaging of mice injected with nonlabeled LNP-siRNA (control group) or LNPs loaded Cy5-labeled siRNA. ( B ) Representative IVIS image illustrating the distribution of LNPs across various organs. ( C ) Flow cytometry analysis showing cellular uptake of Cy5-siRNA in hepatocytes. ASGR1 was used as a hepatocyte specific marker. ( D ) Distribution of Cy5-labeled siRNA among different liver cell populations in healthy mice and MASH mice fed an MCD diet for 8 weeks. Data were presented as the percentage of Cy5-positive cells within each cell type based on FACS analysis. EC, endothelial cells; HSCs, hepatic stellate cells; DCs, dendritic cells. ( E to G ) Time-course analysis of hepatic Sptlc2 mRNA levels and SPTLC2 protein levels following a single intravenous dose of LNP-siRNA (0.3 mg/kg) in MASH mice fed an MCD diet for 4 weeks. Glyceraldehyde-3-phosphate dehydrogenase was used as a loading control for Western blot analysis, and protein expression levels were normalized to that on day 2 postdosing of LNP-Scrambled siRNA (control). ( H ) Time-course analysis of hepatic Sptlc2 mRNA levels in healthy mice following siRNA treatment at 0.3 mg/kg per dose, administered either once or twice weekly. The once-weekly group received doses on days 0 and 7, while the twice-weekly group received doses on days 0, 3, 7, and 10. N = 3 mice per group. * P < 0.05, ** P < 0.01, and *** P < 0.001; one-way ANOVA.

Article Snippet: Cells were stained with an ASGR1 antibody (Proteintech, catalog no. CL488-11739, Illinois, USA) for 30 min at 4°C in the dark.

Techniques: Imaging, Injection, Control, Labeling, Flow Cytometry, Marker, Western Blot, Expressing

( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, LGALS3, and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Scheme depicting proximity biotinylation of proteins in response to recruitment of LGALS1, LGALS3, and LGALS8 proteins to damaged lysosomes. ( B ) Experimental workflow for galectin proximity biotinylation. APEX2-tagged LGALS1, LGALS3, and LGALS8 expressed in HeLa cells were subjected to proximity biotinylation 60 min post-LLOMe treatment using 10-plex TMT. ( C ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS8-based proximity biotinylation based on the TMT experiment in (B). Specific categories of proteins are indicated by colored circles. ( D ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS3-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( E ) Volcano plot for LLOMe (60 min)-treated cells versus untreated cells (Log 2 FC versus −Log 10 p-value) for APEX-LGALS1-based proximity biotinylation based on the TMT experiment in B. Specific categories of proteins are indicated by colored circles. ( F ) Log 2 FC for individual proteins localized to the lysosomal compartment found to be enriched in biotinylated proteins from cells expressing the indicated APEX2-galectin protein. Mean and standard deviation are calculated from two untreated and two treated biological replicates. ( G ) GO: process enrichment categories for APEX2-LGALS8. Figure 3—source data 1. Log 2 FCs for lysosomal proteins from APEX2-LGALS1, 3, and 8 for . Figure 3—source data 2. GO enrichments for APEX2-LGALS8 for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Expressing, Standard Deviation

( A ) Summary of proteins in proximity to galectins and integration with associations found with APEX2-ATG8 (bold) and Lyso-IP (underline). Other functional classes are indicated. ( B ) Localization of LGALS3 with LAMP1 and MAP1LC3B in response to lysosomal damage. Cells were treated with LLOMe for 1 hr and the LLOMe washed out for 4 hr prior to immunofluorescence using the indicated antibodies and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( C ) Cells were left untreated (Untreated), treated with LLOMe for 1 hr and either fixed (LLOMe 1 hr) or the LLOMe was washed out for 4 hr prior to fixation (LLOMe 1 hr+ washout 4 hr). Immunofluorescence was done using α-OPTN/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( D ) Cells were treated as in (C). Immunofluorescence was done using α-TAX1BP1/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( E ) Cells were treated as in (C). Immunofluorescence was done using α-CALCOCO2/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( F ) Quantification of OPTN localization at LAMP1 lysosomes using Mander’s overlap coefficient (MOC). 23 (0 hr), 19 (1 hr), and 22 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. ( G ) Quantification of TAX1BP1 localization at LAMP1 lysosomes using Mander’s overlap coefficient (MOC). 20 (0 hr), 17 (1 hr), and 22 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. ( H ) Quantification of CALCOCO2 localization at LAMP1 lysosomes using MOC. 18 (0 hr), 20 (1 hr), and 21 (4 hr washout) cells were analyzed for MOC. **p < 0.01 and ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. Figure 4—source data 1. Mander’s overlap coefficient (MOC) values for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Summary of proteins in proximity to galectins and integration with associations found with APEX2-ATG8 (bold) and Lyso-IP (underline). Other functional classes are indicated. ( B ) Localization of LGALS3 with LAMP1 and MAP1LC3B in response to lysosomal damage. Cells were treated with LLOMe for 1 hr and the LLOMe washed out for 4 hr prior to immunofluorescence using the indicated antibodies and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( C ) Cells were left untreated (Untreated), treated with LLOMe for 1 hr and either fixed (LLOMe 1 hr) or the LLOMe was washed out for 4 hr prior to fixation (LLOMe 1 hr+ washout 4 hr). Immunofluorescence was done using α-OPTN/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( D ) Cells were treated as in (C). Immunofluorescence was done using α-TAX1BP1/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( E ) Cells were treated as in (C). Immunofluorescence was done using α-CALCOCO2/α-LAMP1 and imaging by confocal microscopy. Scale bars 10 μm. Zoom-in panels, 10 μm × 10 μm. ( F ) Quantification of OPTN localization at LAMP1 lysosomes using Mander’s overlap coefficient (MOC). 23 (0 hr), 19 (1 hr), and 22 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. ( G ) Quantification of TAX1BP1 localization at LAMP1 lysosomes using Mander’s overlap coefficient (MOC). 20 (0 hr), 17 (1 hr), and 22 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. ( H ) Quantification of CALCOCO2 localization at LAMP1 lysosomes using MOC. 18 (0 hr), 20 (1 hr), and 21 (4 hr washout) cells were analyzed for MOC. **p < 0.01 and ***p < 0.001. + marks the mean and the line marks the median. The plot represents merged data from three biological replicates for each condition. Figure 4—source data 1. Mander’s overlap coefficient (MOC) values for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Functional Assay, Immunofluorescence, Imaging, Confocal Microscopy

( A ) Scheme depicting measurement of lysophagic flux using Lyso-Keima (Keima-LGALS3). Cells stably expressing Keima-LGALS3 are treated with LLOMe (1 hr), and the Keima-LGALS3 is recruited from the cytosol to damaged lysosomes, representing the initial recruitment step (green dot). After removing LLOMe (washout), damaged lysosomes undergo autophagy-dependent trafficking to a healthy lysosome, leading to a red-shift in Keima fluorescence (red dots) due to the acidic environment of the lysosome. Cells can be analyzed by imaging, flow cytometry or SDS–PAGE for processed Keima. ( B ) Keima-LGALS3 in untreated HeLa cells or in cells that were treated with LLOMe for 1 hr and the LLOMe washed out for 4 or 12 hr and imaged using excitation at 442 or 561 nm. Scale bar 10 μm. Zoom-in panels, 10 μm × 20 μm. ( C ) Keima-LGALS3 HeLa cells were either left untreated or treated for 1 hr followed by washout (12 hr) with or without prior addition of TBK1i or BafA. Cells were imaged using excitation at 442 or 561 nm. A ratio of the 561 nm/442 nm images was taken and puncta were identified from this 561 nm/442 nm image. Scale bar 10 μm. Zoom-in panels, 10 μm × 20 μm. ( D ) Quantification of Keima-positive lysosomes. 69 (untreated), 83 (BafA), and 66 (TBKi) cells were analyzed ****p < 0.0001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( E ) Triplicate HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) with or without addition of BafA. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( F ) Triplicate HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) with or without prior addition of TBK1i, ULK1i, TAK243, and p97i. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( G ) HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout followed by harvesting at the indicated times. Lysed cells were then subjected to immunoblotting with the indicated antibodies. ( H ) Cells were left untreated (Untreated), treated with LLOMe for 1 hr and either fixed (LLOMe 1 hr) or the LLOMe was washed out for 4 hr prior to fixation (LLOMe 1 hr + washout 4 hr). Immunofluorescence was done using α-pTBK1/α-LAMP1 and imaging by confocal microscopy. Scale bar = 10 μm. Zoom-in panels, 10 μm × 10 μm. Right: quantification of localization using Mander’s overlap coefficient (MOC). 23 (0 hr), 21 (1 hr), and 18 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( I ) HeLa cells expressing Keima-LGALS3 were either left untreated or treated with LLOMe for 1 hr and then incubated for four or 12 hr post-washout in the presence or absence of either BafA or TBK1i. Cell lysates were subjected to immunoblotting using the indicated antibodies. ( J ) Triplicate WT, ATG5 −/− , or TBK1 −/− HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (4 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. Figure 5—source data 1. Quantification of Keima-positive lysosomes. Figure 5—source data 2. 561/488 Keima ratios for . Figure 5—source data 3. 561/488 Keima ratios for . Figure 5—source data 4. Uncropped blots for . Figure 5—source data 5. MOC values for . Figure 5—source data 6. 561/488 Keima ratios for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Scheme depicting measurement of lysophagic flux using Lyso-Keima (Keima-LGALS3). Cells stably expressing Keima-LGALS3 are treated with LLOMe (1 hr), and the Keima-LGALS3 is recruited from the cytosol to damaged lysosomes, representing the initial recruitment step (green dot). After removing LLOMe (washout), damaged lysosomes undergo autophagy-dependent trafficking to a healthy lysosome, leading to a red-shift in Keima fluorescence (red dots) due to the acidic environment of the lysosome. Cells can be analyzed by imaging, flow cytometry or SDS–PAGE for processed Keima. ( B ) Keima-LGALS3 in untreated HeLa cells or in cells that were treated with LLOMe for 1 hr and the LLOMe washed out for 4 or 12 hr and imaged using excitation at 442 or 561 nm. Scale bar 10 μm. Zoom-in panels, 10 μm × 20 μm. ( C ) Keima-LGALS3 HeLa cells were either left untreated or treated for 1 hr followed by washout (12 hr) with or without prior addition of TBK1i or BafA. Cells were imaged using excitation at 442 or 561 nm. A ratio of the 561 nm/442 nm images was taken and puncta were identified from this 561 nm/442 nm image. Scale bar 10 μm. Zoom-in panels, 10 μm × 20 μm. ( D ) Quantification of Keima-positive lysosomes. 69 (untreated), 83 (BafA), and 66 (TBKi) cells were analyzed ****p < 0.0001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( E ) Triplicate HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) with or without addition of BafA. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( F ) Triplicate HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) with or without prior addition of TBK1i, ULK1i, TAK243, and p97i. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( G ) HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout followed by harvesting at the indicated times. Lysed cells were then subjected to immunoblotting with the indicated antibodies. ( H ) Cells were left untreated (Untreated), treated with LLOMe for 1 hr and either fixed (LLOMe 1 hr) or the LLOMe was washed out for 4 hr prior to fixation (LLOMe 1 hr + washout 4 hr). Immunofluorescence was done using α-pTBK1/α-LAMP1 and imaging by confocal microscopy. Scale bar = 10 μm. Zoom-in panels, 10 μm × 10 μm. Right: quantification of localization using Mander’s overlap coefficient (MOC). 23 (0 hr), 21 (1 hr), and 18 (4 hr washout) cells were analyzed for MOC. ***p < 0.001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( I ) HeLa cells expressing Keima-LGALS3 were either left untreated or treated with LLOMe for 1 hr and then incubated for four or 12 hr post-washout in the presence or absence of either BafA or TBK1i. Cell lysates were subjected to immunoblotting using the indicated antibodies. ( J ) Triplicate WT, ATG5 −/− , or TBK1 −/− HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (4 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. Figure 5—source data 1. Quantification of Keima-positive lysosomes. Figure 5—source data 2. 561/488 Keima ratios for . Figure 5—source data 3. 561/488 Keima ratios for . Figure 5—source data 4. Uncropped blots for . Figure 5—source data 5. MOC values for . Figure 5—source data 6. 561/488 Keima ratios for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Stable Transfection, Expressing, Fluorescence, Imaging, Flow Cytometry, SDS Page, Standard Deviation, Western Blot, Immunofluorescence, Confocal Microscopy, Incubation

( A ) Raw flow cytometry data. HeLa cells expressing Keima-LGALS3 were either left untreated (red), or treated for 1 hr followed by washout (12 hr) with (orange) or without (blue) addition of BafA. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. ( B ) HeLa cells expressing Keima-LGALS3 were treated with LLOMe (1 hr) prior to washout for 4 or 8 hr. In one set of samples, the E1 inhibitor TAK243 at 2 μM was added prior to damage. Cell extracts at the indicated time were subjected to immunoblotting with the indicated antibodies. Figure 5—figure supplement 1—source data 1. Uncropped blots.

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Raw flow cytometry data. HeLa cells expressing Keima-LGALS3 were either left untreated (red), or treated for 1 hr followed by washout (12 hr) with (orange) or without (blue) addition of BafA. Cells were then subjected to flow cytometry to measure the 561 nm/488 nm ratio. ( B ) HeLa cells expressing Keima-LGALS3 were treated with LLOMe (1 hr) prior to washout for 4 or 8 hr. In one set of samples, the E1 inhibitor TAK243 at 2 μM was added prior to damage. Cell extracts at the indicated time were subjected to immunoblotting with the indicated antibodies. Figure 5—figure supplement 1—source data 1. Uncropped blots.

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Flow Cytometry, Expressing, Western Blot

( A ) Triplicate WT; ATG5 −/− ; or OPTN −/− ; TAX1BP1 −/− ; CALCOCO2 −/− (TKO) HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. ( B ) Triplicate WT or TKO HeLa cells expressing Keima-LGALS3 were reconstituted with lentivirally expressed EGFP-FLAG-HA, EGFP-CALCOCO2, EGFP-OPTN, or EGFP-TAX1BP1. Cells were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. As a control for lysophagic flux, some samples were also treated with BafA during the washout. All values are normalized to the untreated sample within each genotype. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( C ) Cells from panel B were lysed and subjected to immunoblotting with the indicated antibodies. ( D ) HeLa cells expressing Keima-LGALS3 (with or without deletion of ATG7, TAX1BP1, OPTN, CALCOCO2, or SQSTM1) were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( E ) HeLa cells (with or without deletion of TAX1BP1, OPTN, CALCOCO2, or SQSTM1) were either left untreated or treated for 1 hr followed by washout (10 hr) prior to immunostaining with α-LAMP1 (green) and α-LGALS3 (magenta). The number of LGALS3 puncta per cell present after washout is plotted (right top panel). The block to lysophagic flux was rescued by expression of EGFP-TAX1BP1 but not EGFP (lower right panel). 41 (WT), 21 (TAX1BP1), 25 (OPTN), 21 (CALCOCO2), and 27 (SQSTM1) cells were analyzed in the upper graph. 29 (WT), 28 (EGFP), and 32 (EGFP-TAX1BP1) cells were analyzed in the bottom graph. ****p < 0.0001. Scale bar 10 μm. Zoom-in panels, 10 μm × 10 μm. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. Figure 6—source data 1. 561/488 Keima ratios for . Figure 6—source data 2. 561/488 Keima ratios for . Figure 6—source data 3. 561/488 Keima ratios for . Figure 6—source data 4. The number of galectin puncta per cell post-washout for . Figure 6—source data 5. Uncropped blots for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Triplicate WT; ATG5 −/− ; or OPTN −/− ; TAX1BP1 −/− ; CALCOCO2 −/− (TKO) HeLa cells expressing Keima-LGALS3 were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. ( B ) Triplicate WT or TKO HeLa cells expressing Keima-LGALS3 were reconstituted with lentivirally expressed EGFP-FLAG-HA, EGFP-CALCOCO2, EGFP-OPTN, or EGFP-TAX1BP1. Cells were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. As a control for lysophagic flux, some samples were also treated with BafA during the washout. All values are normalized to the untreated sample within each genotype. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( C ) Cells from panel B were lysed and subjected to immunoblotting with the indicated antibodies. ( D ) HeLa cells expressing Keima-LGALS3 (with or without deletion of ATG7, TAX1BP1, OPTN, CALCOCO2, or SQSTM1) were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. ****p < 0.0001. The plot represents mean and standard deviation from three biological replicates. ( E ) HeLa cells (with or without deletion of TAX1BP1, OPTN, CALCOCO2, or SQSTM1) were either left untreated or treated for 1 hr followed by washout (10 hr) prior to immunostaining with α-LAMP1 (green) and α-LGALS3 (magenta). The number of LGALS3 puncta per cell present after washout is plotted (right top panel). The block to lysophagic flux was rescued by expression of EGFP-TAX1BP1 but not EGFP (lower right panel). 41 (WT), 21 (TAX1BP1), 25 (OPTN), 21 (CALCOCO2), and 27 (SQSTM1) cells were analyzed in the upper graph. 29 (WT), 28 (EGFP), and 32 (EGFP-TAX1BP1) cells were analyzed in the bottom graph. ****p < 0.0001. Scale bar 10 μm. Zoom-in panels, 10 μm × 10 μm. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. Figure 6—source data 1. 561/488 Keima ratios for . Figure 6—source data 2. 561/488 Keima ratios for . Figure 6—source data 3. 561/488 Keima ratios for . Figure 6—source data 4. The number of galectin puncta per cell post-washout for . Figure 6—source data 5. Uncropped blots for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Expressing, Flow Cytometry, Standard Deviation, Control, Western Blot, Immunostaining, Blocking Assay

( A ) RFP-EGFP-LGALS3 is trafficked to lysosomes in iNeurons. ES cells expressing RFP-EGFP-LGALS3 via a PiggyBac vector were converted to iNeurons using inducible NGN2 (see Materials and methods) and imaged for EGFP, RFP, and LAMP1 using α-LAMP1 antibodies. While EGFP signal was diffusely localized in the soma, RFP-positive puncta colocalized with lysosomes based on colocalization with LAMP1 staining, indicating that a subset of the RFP-EGFP-LGALS3 protein is trafficked to the lysosome under basal conditions. Scale bar = 20 μm. iN soma zoom-in panels, 30 μm × 40 μm. ( B ) iNeurons expressing RFP-EGFP-LGALS3 were either left untreated, treated with LLOMe for 1 hr, or treated with LLOMe for 1 hr followed by a 12 hr washout. Cells were imaged for EGFP and RFP and the number of EGFP puncta per cell quantified. Loss of EGFP puncta during the washout period is indicative of lysophagic flux. Scale bar = 20 μm. ( C ) Quantification of EGFP puncta per cell after washout from experiments in panel B. The average EGFP puncta per cell was 0.289 at 0 hr (45 cells), 6.46 at 1 hr LLOMe (55 cells) and 0.652 at 12 hr washout after LLOMe (66 cells). ****p < 0.0001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( D ) iNeurons were subjected to LLOMe treatment and washout as in panel B but treated with or without TBK1i, VPS34i, or BafA during the washout period. Cells were imaged for EGFP and RFP. Scale bar = 20 μm. iN soma zoom-in panels, 30 μm × 40 μm. ( E ) Quantification of EGFP puncta per cell from the experiment in panel D. The average EGFP puncta per cell at 12 hr washout was 0.65 with no inhibitor (66 cells), 5.14 with BafA (49 cells), 11.95 with VPS34i (44 cells), and 5.84 with TBKi (63 cells). ****p < 0.0001, ***p < 0.001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( F ) WT, TAX1BP1 −/− , or TAX1BP1 −/− ; OPTN −/− iNeurons were subjected to LLOMe treatment and washout as in panel B. Cells were imaged for EGFP and RFP. Scale bar = 10 μm. iN soma zoom-in panels, 20 μm × 20 μm. ( G ) Quantification of EGFP puncta per cell from the experiment in panel F. The average EGFP puncta per cell at 12hr washout after LLOMe for wild-type cells was 0.474 (38 cells), for TAX1BP1 −/− cells was 4.36 (62 cells) and for TAX1BP1 −/− ; OPTN −/− cells was 4.03 (39 cells). ****p < 0.0001, **p< 0.01. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. Figure 7—source data 1. The number of GFP puncta per cell for . Figure 7—source data 2. The number of GFP puncta per cell for . Figure 7—source data 3. The number of GFP puncta per cell for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) RFP-EGFP-LGALS3 is trafficked to lysosomes in iNeurons. ES cells expressing RFP-EGFP-LGALS3 via a PiggyBac vector were converted to iNeurons using inducible NGN2 (see Materials and methods) and imaged for EGFP, RFP, and LAMP1 using α-LAMP1 antibodies. While EGFP signal was diffusely localized in the soma, RFP-positive puncta colocalized with lysosomes based on colocalization with LAMP1 staining, indicating that a subset of the RFP-EGFP-LGALS3 protein is trafficked to the lysosome under basal conditions. Scale bar = 20 μm. iN soma zoom-in panels, 30 μm × 40 μm. ( B ) iNeurons expressing RFP-EGFP-LGALS3 were either left untreated, treated with LLOMe for 1 hr, or treated with LLOMe for 1 hr followed by a 12 hr washout. Cells were imaged for EGFP and RFP and the number of EGFP puncta per cell quantified. Loss of EGFP puncta during the washout period is indicative of lysophagic flux. Scale bar = 20 μm. ( C ) Quantification of EGFP puncta per cell after washout from experiments in panel B. The average EGFP puncta per cell was 0.289 at 0 hr (45 cells), 6.46 at 1 hr LLOMe (55 cells) and 0.652 at 12 hr washout after LLOMe (66 cells). ****p < 0.0001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( D ) iNeurons were subjected to LLOMe treatment and washout as in panel B but treated with or without TBK1i, VPS34i, or BafA during the washout period. Cells were imaged for EGFP and RFP. Scale bar = 20 μm. iN soma zoom-in panels, 30 μm × 40 μm. ( E ) Quantification of EGFP puncta per cell from the experiment in panel D. The average EGFP puncta per cell at 12 hr washout was 0.65 with no inhibitor (66 cells), 5.14 with BafA (49 cells), 11.95 with VPS34i (44 cells), and 5.84 with TBKi (63 cells). ****p < 0.0001, ***p < 0.001. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. ( F ) WT, TAX1BP1 −/− , or TAX1BP1 −/− ; OPTN −/− iNeurons were subjected to LLOMe treatment and washout as in panel B. Cells were imaged for EGFP and RFP. Scale bar = 10 μm. iN soma zoom-in panels, 20 μm × 20 μm. ( G ) Quantification of EGFP puncta per cell from the experiment in panel F. The average EGFP puncta per cell at 12hr washout after LLOMe for wild-type cells was 0.474 (38 cells), for TAX1BP1 −/− cells was 4.36 (62 cells) and for TAX1BP1 −/− ; OPTN −/− cells was 4.03 (39 cells). ****p < 0.0001, **p< 0.01. + marks the mean and the line is at the median. The plot represents merged data from three biological replicates. Figure 7—source data 1. The number of GFP puncta per cell for . Figure 7—source data 2. The number of GFP puncta per cell for . Figure 7—source data 3. The number of GFP puncta per cell for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Expressing, Plasmid Preparation, Staining

( A ) iNeurons stably expressing RFP-EGFP-LGALS3 R186S were either left untreated, treated with LLOMe for 1 hr, or treated with LLOMe for 1 hr followed by a 12hr washout. Cells were imaged for EGFP and RFP. Scale bar = 10 μm. Zoom-in panels, 10 μm × 10 μm. ( B ) Quantification of GFP puncta per cell after washout from experiments in panel A demonstrates the absence of GFP-positive puncta in response to lysosomal damage. + marks the mean and the line is at the median. The plot represents data from one replicate. ( C ) RFP-positive puncta in cells expressing RFP-EGFP-LGALS3 WT or the R186S mutant demonstrates comparable number of puncta. + marks the mean and the line is at the median. The plot represents data from one replicate. ( D ) TAX1BP1 lesion read by Illumina Miseq analysis. ( E ) Extracts from WT or TAX1BP1 −/− ES cells were immunoblotted with the indicated antibodies to demonstrate deletion of TAX1BP1. ( F ) OPTN lesion read by Illumina Miseq analysis. ( G ) Extracts from WT, TAX1BP1 −/− , or TAX1BP1 −/− ; OPTN −/− ES cells were immunoblotted with the indicated antibodies to demonstrate deletion of OPTN and TAX1BP1 . Figure 7—figure supplement 1—source data 1. The number of EGFP puncta per cell for . Figure 7—figure supplement 1—source data 2. Uncropped blots for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) iNeurons stably expressing RFP-EGFP-LGALS3 R186S were either left untreated, treated with LLOMe for 1 hr, or treated with LLOMe for 1 hr followed by a 12hr washout. Cells were imaged for EGFP and RFP. Scale bar = 10 μm. Zoom-in panels, 10 μm × 10 μm. ( B ) Quantification of GFP puncta per cell after washout from experiments in panel A demonstrates the absence of GFP-positive puncta in response to lysosomal damage. + marks the mean and the line is at the median. The plot represents data from one replicate. ( C ) RFP-positive puncta in cells expressing RFP-EGFP-LGALS3 WT or the R186S mutant demonstrates comparable number of puncta. + marks the mean and the line is at the median. The plot represents data from one replicate. ( D ) TAX1BP1 lesion read by Illumina Miseq analysis. ( E ) Extracts from WT or TAX1BP1 −/− ES cells were immunoblotted with the indicated antibodies to demonstrate deletion of TAX1BP1. ( F ) OPTN lesion read by Illumina Miseq analysis. ( G ) Extracts from WT, TAX1BP1 −/− , or TAX1BP1 −/− ; OPTN −/− ES cells were immunoblotted with the indicated antibodies to demonstrate deletion of OPTN and TAX1BP1 . Figure 7—figure supplement 1—source data 1. The number of EGFP puncta per cell for . Figure 7—figure supplement 1—source data 2. Uncropped blots for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Stable Transfection, Expressing, Mutagenesis

( A ) Domain structure of TAX1BP1 showing the location of mutations examined in this study. ( B ) Domain structure of OPTN showing the location of mutations examined in this study. ( C ) HeLa TKO cells expressing Keima-LGALS3 were infected with lentiviruses expressing GFP-tagged WT or mutant TAX1BP1 proteins to obtain stable expression. Cells in biological triplicate were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. ****p < 0.0001 ( D ) Immunoblot of cell extracts from panel C probed with α-TAX1BP1 or α-actin as a loading control. Note that some mutants are highly stabilized, as reported previously . The EGFP-TAX1BP1 CC2Δ mutant is not detected by western blot due to the loss of the epitope-binding site of the antibody, nevertheless is detected by FACS . ( E ) HeLa TKO cells expressing Keima-LGALS3 were infected with lentiviruses expressing GFP-tagged WT or mutant OPTN proteins to obtain stable expression. Cells in biological triplicate were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. The plot represents mean and standard deviation from three biological replicates. ****p < 0.0001. ( F ) Immunoblot of cell extracts from panel E probed with α-GFP or α-actin as a loading control. ( G ) HeLa TKO cells were infected with lentiviruses expressing EGFP-tagged WT or mutant TAX1BP1 proteins to obtain stable expression. Cells were either left untreated or treated for 1 hr with LLOMe followed by washout. Cells were harvested at the indicated times and subjected to immunoblotting with the indicated antibodies. ( H ) HeLa TKO cells were infected with lentiviruses expressing EGFP-tagged WT or mutant OPTN proteins to obtain stable expression. Cells were either left untreated or treated for 1 hr with LLOMe followed by washout (12 hr). Cells were harvested at the indicated times and subjected to immunoblotting with the indicated antibodies. ( I ) Model figure. Lysosomal rupture leads to the parallel recruitment of galectins and unleashes a wave of ubiquitination on the lysosome (Steps 1a and b). In step 2, ubiquitination promotes the recruitment of both OPTN-TBK1 and TAX1BP1-TBK1-RB1CC1 complexes to the damage lysosome, thereby promoting de novo phagophore formation and local TBK1 activation to drive efficient lysophagy (Steps 3–5). Figure 8—source data 1. 561/488 Keima ratios for . Figure 8—source data 2. 561/488 Keima ratios for . Figure 8—source data 3. Uncropped blots for .

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet: ( A ) Domain structure of TAX1BP1 showing the location of mutations examined in this study. ( B ) Domain structure of OPTN showing the location of mutations examined in this study. ( C ) HeLa TKO cells expressing Keima-LGALS3 were infected with lentiviruses expressing GFP-tagged WT or mutant TAX1BP1 proteins to obtain stable expression. Cells in biological triplicate were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. All values are normalized to the untreated sample within each genotype. The plot represents mean and standard deviation from three biological replicates. ****p < 0.0001 ( D ) Immunoblot of cell extracts from panel C probed with α-TAX1BP1 or α-actin as a loading control. Note that some mutants are highly stabilized, as reported previously . The EGFP-TAX1BP1 CC2Δ mutant is not detected by western blot due to the loss of the epitope-binding site of the antibody, nevertheless is detected by FACS . ( E ) HeLa TKO cells expressing Keima-LGALS3 were infected with lentiviruses expressing GFP-tagged WT or mutant OPTN proteins to obtain stable expression. Cells in biological triplicate were either left untreated or treated for 1 hr followed by washout (12 hr) prior to flow cytometry to measure the 561 nm/488 nm ratio. The plot represents mean and standard deviation from three biological replicates. ****p < 0.0001. ( F ) Immunoblot of cell extracts from panel E probed with α-GFP or α-actin as a loading control. ( G ) HeLa TKO cells were infected with lentiviruses expressing EGFP-tagged WT or mutant TAX1BP1 proteins to obtain stable expression. Cells were either left untreated or treated for 1 hr with LLOMe followed by washout. Cells were harvested at the indicated times and subjected to immunoblotting with the indicated antibodies. ( H ) HeLa TKO cells were infected with lentiviruses expressing EGFP-tagged WT or mutant OPTN proteins to obtain stable expression. Cells were either left untreated or treated for 1 hr with LLOMe followed by washout (12 hr). Cells were harvested at the indicated times and subjected to immunoblotting with the indicated antibodies. ( I ) Model figure. Lysosomal rupture leads to the parallel recruitment of galectins and unleashes a wave of ubiquitination on the lysosome (Steps 1a and b). In step 2, ubiquitination promotes the recruitment of both OPTN-TBK1 and TAX1BP1-TBK1-RB1CC1 complexes to the damage lysosome, thereby promoting de novo phagophore formation and local TBK1 activation to drive efficient lysophagy (Steps 3–5). Figure 8—source data 1. 561/488 Keima ratios for . Figure 8—source data 2. 561/488 Keima ratios for . Figure 8—source data 3. Uncropped blots for .

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Expressing, Infection, Mutagenesis, Flow Cytometry, Standard Deviation, Western Blot, Control, Binding Assay, Ubiquitin Proteomics, Activation Assay

Journal: eLife

Article Title: Quantitative proteomics reveals the selectivity of ubiquitin-binding autophagy receptors in the turnover of damaged lysosomes by lysophagy

doi: 10.7554/eLife.72328

Figure Lengend Snippet:

Article Snippet: Antibody , Galectin-3/ LGALS3 (Rabbit Antibody, polyclonal) , Proteintech , 60207–1-I; RRID: AB_10951109 , IF (1:300), WB (1:1000).

Techniques: Immunofluorescence, Magnetic Beads, Peptide Fractionation, Protease Inhibitor, Recombinant, Staining, Plasmid Preparation, Software

 Lectins  detected in the neurons by co-localization .

Journal: Frontiers in Nutrition

Article Title: Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans , a Potential Etiology of Parkinson’s Disease

doi: 10.3389/fnut.2016.00007

Figure Lengend Snippet: Lectins detected in the neurons by co-localization .

Article Snippet: Commercially available plant lectins conjugated to TRITC or rhodamine were from EY labs (San Mateo, CA, USA), Vector Labs (Burlingame, CA, USA), or Sigma-Aldrich (St. Louis, MO, USA).

Techniques:

 Lectins  alter number, GFP-intensity, or size of DAergic neurons without observed co-localization .

Journal: Frontiers in Nutrition

Article Title: Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans , a Potential Etiology of Parkinson’s Disease

doi: 10.3389/fnut.2016.00007

Figure Lengend Snippet: Lectins alter number, GFP-intensity, or size of DAergic neurons without observed co-localization .

Article Snippet: Commercially available plant lectins conjugated to TRITC or rhodamine were from EY labs (San Mateo, CA, USA), Vector Labs (Burlingame, CA, USA), or Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Fluorescence

Protein and lectin staining of released E. coli surface proteins. NT: Non-treated, AH: Acid-hydrolyzed, LF: AIEC LF82. MG: E. coli MG1655. (A) Coomassie blue stain, (B) Anti-type I fimbriae-FITC staining, (C) ConA-HRP staining.

Journal: bioRxiv

Article Title: Biochemical characterization of the Escherichia coli surfaceome: A focus on type I fimbriae and flagella

doi: 10.1101/2024.01.14.575581

Figure Lengend Snippet: Protein and lectin staining of released E. coli surface proteins. NT: Non-treated, AH: Acid-hydrolyzed, LF: AIEC LF82. MG: E. coli MG1655. (A) Coomassie blue stain, (B) Anti-type I fimbriae-FITC staining, (C) ConA-HRP staining.

Article Snippet: HRP-conjugated galanthus nivalis lectin (GNA) was obtained from USBiological (CliniSciences, Nanterre; G1044-25).

Techniques: Staining

Lectin staining of released E. coli surface proteins. (A) GNA-HRP staining. Lane 1: Mock-treated LF82; Lane 2: PNGase F-treated LF82; Lane 3: Acid hydrolyzed E. coli MG1655; Lane 4: Untreated MG1655; Lane 5: Mock-treated MG1655; Lane 6: PNGase F-treated MG1655. C: PNGase F enzyme only control; M: Molecular weight ladder. (B) WGA-biotin staining. Lane 1: LF82 non-hydrolyzed; Lane 2: LF82 acid-hydrolyzed; Lane 3: MG1655 non-hydrolyzed; Lane 4: MG1655 acid-hydrolyzed.

Journal: bioRxiv

Article Title: Biochemical characterization of the Escherichia coli surfaceome: A focus on type I fimbriae and flagella

doi: 10.1101/2024.01.14.575581

Figure Lengend Snippet: Lectin staining of released E. coli surface proteins. (A) GNA-HRP staining. Lane 1: Mock-treated LF82; Lane 2: PNGase F-treated LF82; Lane 3: Acid hydrolyzed E. coli MG1655; Lane 4: Untreated MG1655; Lane 5: Mock-treated MG1655; Lane 6: PNGase F-treated MG1655. C: PNGase F enzyme only control; M: Molecular weight ladder. (B) WGA-biotin staining. Lane 1: LF82 non-hydrolyzed; Lane 2: LF82 acid-hydrolyzed; Lane 3: MG1655 non-hydrolyzed; Lane 4: MG1655 acid-hydrolyzed.

Article Snippet: HRP-conjugated galanthus nivalis lectin (GNA) was obtained from USBiological (CliniSciences, Nanterre; G1044-25).

Techniques: Staining, Molecular Weight

ConA lectin probing following PNGase or mannosidase treatment of released E. coli surface proteins. LF: AIEC LF82, MG: E. coli MG1655. NT: Non-acid hydrolyzed, AH: Acid hydrolyzed, L: Molecular weight ladder, Mock: Mock-treated sample, Man: Mannosidase-treated sample. (A) PNGase F treatment probed with ConA. (B) Anti-type I fimbria staining of membrane (A). (C) Mannosidase treatment probed with ConA.

Journal: bioRxiv

Article Title: Biochemical characterization of the Escherichia coli surfaceome: A focus on type I fimbriae and flagella

doi: 10.1101/2024.01.14.575581

Figure Lengend Snippet: ConA lectin probing following PNGase or mannosidase treatment of released E. coli surface proteins. LF: AIEC LF82, MG: E. coli MG1655. NT: Non-acid hydrolyzed, AH: Acid hydrolyzed, L: Molecular weight ladder, Mock: Mock-treated sample, Man: Mannosidase-treated sample. (A) PNGase F treatment probed with ConA. (B) Anti-type I fimbria staining of membrane (A). (C) Mannosidase treatment probed with ConA.

Article Snippet: HRP-conjugated galanthus nivalis lectin (GNA) was obtained from USBiological (CliniSciences, Nanterre; G1044-25).

Techniques: Molecular Weight, Staining, Membrane